The effect of HapMap on cardiovascular research and clinical practice

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 3, 2007, Pages 136-142

  Skelding, Kimberly A ^a   Gerhard, Glenn S ^b   Simari, Robert D ^c   Holmes, David R ^d  

^a GEISINGER MEDICAL CENTER   (United States)

^b Geisinger Clinic   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA; INTERSTITIAL COLLAGENASE; KEXIN; LACTASE; MENADIONE EPOXIDE; RNA; SCLEROPROTEIN; SUBTILISIN;

CARDIOLOGIST; CARDIOVASCULAR DISEASE; CHROMOSOME ANALYSIS; CLINICAL EFFECTIVENESS; CLINICAL LABORATORY; CLINICAL PRACTICE; CLINICAL RESEARCH; FAMILIAL HYPERCHOLESTEROLEMIA; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE MAP; HEART INFARCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOLOGY; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC RESEARCH; HAPLOTYPES; HUMANS; RETROSPECTIVE STUDIES;

EID: 33847658686     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0830     Document Type: Review

References (54)

1. Altshuler D et al. (2005) A haplotype map of the human genome. Nature 437: 1299-1320
2. Schmidt CW (2003) HapMap: Building a database with blocks. EHP Toxicogenomics 111: A16
3. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796
4. Thorisson GA et al. (2005) The International HapMap Project web site. Genome Res 15: 1592-1593
5. The International HapMap Consortium (2004) Integrating ethics and science in the International HapMap Project. Nat Rev Genet 5: 467-475
6. Kastrati A et al. (2006) Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxeleluting stents. Circulation 113: 2293-2300
7. Di Castelnuovo A et al. (2005) Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: Implications for clinical practice. Am J Pharmacogenomics 5: 93-99
8. Koch W et al. (2004) Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting. J Lipid Res 45: 2221-2226
9. Koch W et al. (2004) Peroxisome proliferator-activated receptor gamma gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries. Diabetologia 47: 1126-1127
10. Angiolillo DJ et al. (2004) 807 C/T Polymorphism of the glycoprotein la gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment. Blood Coagul Fibrinolysis 15: 427-433
11. Angiolillo DJ et al. (2004) High clopidogrel loading dose during coronary stenting: Effects on drug response and interindividual variability. Eur Heart J 25: 1903-1910
12. Angiolillo DJ et al. (2004) PIA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation. Blood Coagul Fibrinolysis 15: 89-93
13. Angiolillo DJ et al. (2004) Platelet aggregation according to body mass index in patients undergoing coronary stenting: Should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol 16: 169-174
14. Chen SN et al. (2005) A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol 45: 1611-1619
15. Bezzina CR et al. (2006) Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113: 338-344
16. Anderson JL et al. (2000) A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol 36: 1248-1252
17. Hingorani AD et al. (1999) A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100: 1515-1520
18. Doris PA (2002) Hypertension genetics, single nucleotide polymorphisms, and the common disease: Common variant hypothesis. Hypertension 39: 323-331
19. Samuels ME et al. (2001) Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: The -93G/D9N variant predisposes to low HDL-C/high triglycerides. Clin Genet 59: 88-98
20. Pritchard JK and Cox NJ (2002) The allelic architecture of human disease genes: Common disease-common variant...or not? Hum Mol Genet 11: 2417-2423
21. Lunetta KL et al. (2004) Screening large-scale association study data: exploiting interactions using random forests. BMC Genet 5: 32
22. de Bakker PI et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223
23. Lander ES et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921
24. ENCODE Project Consortium (2004) The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306: 636-640
25. Waterston RH et al. (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562
26. Stoneking M (2001) Single nucleotide polymorphisms: From the evolutionary past. Nature 409: 821-822
27. The International HapMap Project [http://www.hapmap.org]
28. Agema WR et al. (2002) A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: Evidence for publication bias. Am Heart J 144: 760-768
29. Amant C et al. (1997) D allele of the angiotensin 1-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 96: 56-60
30. Rakugi H et al. (1994) Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 93: 339-346
31. Wijpkema JS et al. (2006) Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/ C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenet Genomics 16: 331-337
32. Koch W et al. (2006) Association of transforming growth factor-β1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol 26: 1114-1119
33. Koch WJ (2004) Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure. Mol Cell Biochem 263: 5-9
34. Faxon DP et al. (1984) Determinants of successful percutaneous transluminal coronary angioplasty: Report from the National Heart, Lung, and Blood Institute Registry. Am Heart J 108: 1019-1023
35. Holmes DR Jr et al. (1984) Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 53: 77C-81C
36. Venter JC et al. (2001) The sequence of the human genome. Science 291: 1304-1351
37. Goldstein DB and Weale ME (2001) Population genomics: Linkage disequilibrium holds the key. Curr Biol 11: R576-R579
38. Smith AV et al. (2005) Sequence features in regions of weak and strong linkage disequilibrium. Genome Res 15: 1519-1534
39. Hinds DA et al. (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307: 1072-1079
40. Nielsen R et al. (2005) Genomic scans for selective sweeps using SNP data. Genome Res 15: 1566-1575
41. Weir BS et al. (2005) Measures of human population structure show heterogeneity among genomic regions. Genome Res 15: 1468-1476
42. Forouhi NG and Sattar N (2006) CVD risk factors and ethnicity - a homogeneous relationship? Atheroscler 7 (Suppl): 11-19
43. Bertoni AG et al. (2006) Diabetic cardiomyopathy and subclinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 29: 588-594
44. McCluskey J and Peh CA (1999) The human leucocyte antigens and clinical medicine: An overview. Rev Immunogenet 1: 3-20
45. Pearce E et al. (2005) Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 97: 1070-1076
46. Kruger WD et al. (2000) Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab 70: 53-60
47. Wang Y et al. (2006) VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113: 1615-1621
48. Weinshilboum R (2003) Inheritance and drug response. N Engl J Med 348: 529-537
49. Ganesh SK et al. (2004) Rationale and study design of the CardioGene Study: Genomics of in-stent restenosis. Pharmacogenomics 5: 952-1004
50. Ganesh SK and Skelding KA et al., Genome-wide association study of in-stent restenosis identifies multiple candidate susceptibility loci. Presented at the AHA Scientific Sessions: 2006 November 12-15, Chicago
51. Faxon DP et al. (1984) Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina. Report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Surgery Study Registries. Am J Cardiol 53: 131C-135C
52. Lievers KJ et al. (2006) Association of a 31 bp VNTR in the CBS gene with postload homocysteine concentrations in the Framingham Offspring Study. Eur J Hum Genet 14: 1125-1129
53. Wang TH et al. (2005) Aspirin and clopidogrel resistance: An emerging clinical entity. Eur Heart J 27: 647-654
54. Shivakumar L and Armitage JO (2006) Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma. Clin Lymphoma Myeloma 6: 455-457